Long Term Clinical Outcomes of Paclitaxel Drug Eluting Stent in Diabetic Population

Long Term Clinical Outcomes of Paclitaxel Drug Eluting Stent in Diabetic Population

Antimitotic agents like a microtubular stabilizing agent would be better in diabetics to prevent the reverse activation of protein kinase B. Whether paclitaxel on a thinner strut eliminate the differences in the long term clinical outcomes in diabetics was studied.

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The American journal of cardiology 2013-04, Vol.111 (7), p.31B-31B
Hauptverfasser: Tummala, Karthik, Maniyal, Vijay Kumar, Chandrashekar, Rajiv, Kumaraswamy, Natarajan, Kamath, Prakash
Format: Artikel
Sprache:eng
Schlagworte:
Cardiovascular
Clinical outcomes
Kinases
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Antimitotic agents like a microtubular stabilizing agent would be better in diabetics to prevent the reverse activation of protein kinase B. Whether paclitaxel on a thinner strut eliminate the differences in the long term clinical outcomes in diabetics was studied.
ISSN:0002-9149
1879-1913
DOI:10.1016/j.amjcard.2013.01.079